teratogenic risk from tazarotenic acid in semen
Download
Skip this Video
Download Presentation
Teratogenic risk from Tazarotenic acid in semen

Loading in 2 Seconds...

play fullscreen
1 / 1

Teratogenic risk from Tazarotenic acid in semen - PowerPoint PPT Presentation


  • 82 Views
  • Uploaded on

Teratogenic risk from Tazarotenic acid in semen. 831 ng drug in semen which is about 1/ 5,000th of a single 4.5 mg capsule This is about 1/6,000 of the highest oral dose that was not teratogenic in animals.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Teratogenic risk from Tazarotenic acid in semen' - kuame-barnett


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
teratogenic risk from tazarotenic acid in semen
Teratogenic risk from Tazarotenic acid in semen
  • 831 ng drug in semen which is about 1/ 5,000th of a single 4.5 mg capsule
  • This is about 1/6,000 of the highest oral dose that was not teratogenic in animals.
  • However, human may be more sensitive than animals. So instead of 1/6000 this may be only 1/600 to 1/16 human teratogenic dose based on data from other retinoids. Plus, the vaginal route may produce greater exposure to the fetus than the oral route. So this safety margin may be reduced even more.
ad